164 related articles for article (PubMed ID: 36508071)
1. Cisplatin and AKI: an ongoing battle with new perspectives-a narrative review.
Volovat S; Apetrii M; Stefan A; Vlad C; Voroneanu L; Hogas M; Haisan A; Volovat C; Hogas S
Int Urol Nephrol; 2023 May; 55(5):1205-1209. PubMed ID: 36508071
[TBL] [Abstract][Full Text] [Related]
2. Natural products: potential treatments for cisplatin-induced nephrotoxicity.
Fang CY; Lou DY; Zhou LQ; Wang JC; Yang B; He QJ; Wang JJ; Weng QJ
Acta Pharmacol Sin; 2021 Dec; 42(12):1951-1969. PubMed ID: 33750909
[TBL] [Abstract][Full Text] [Related]
3. Nephrotoxicity of cisplatin combination chemotherapy in thoracic malignancy patients with CKD risk factors.
Sato K; Watanabe S; Ohtsubo A; Shoji S; Ishikawa D; Tanaka T; Nozaki K; Kondo R; Okajima M; Miura S; Tanaka J; Sakagami T; Koya T; Kagamu H; Yoshizawa H; Narita I
BMC Cancer; 2016 Mar; 16():222. PubMed ID: 26979596
[TBL] [Abstract][Full Text] [Related]
4. Cisplatin Nephrotoxicity: Novel Insights Into Mechanisms and Preventative Strategies.
Motwani SS; Kaur SS; Kitchlu A
Semin Nephrol; 2022 Nov; 42(6):151341. PubMed ID: 37182407
[TBL] [Abstract][Full Text] [Related]
5. 7-Hydroxycoumarin protects against cisplatin-induced acute kidney injury by inhibiting necroptosis and promoting Sox9-mediated tubular epithelial cell proliferation.
Wu WF; Wang JN; Li Z; Wei B; Jin J; Gao L; Li HD; Li J; Chen HY; Meng XM
Phytomedicine; 2020 Apr; 69():153202. PubMed ID: 32169782
[TBL] [Abstract][Full Text] [Related]
6. DNA damage response in cisplatin-induced nephrotoxicity.
Zhu S; Pabla N; Tang C; He L; Dong Z
Arch Toxicol; 2015 Dec; 89(12):2197-205. PubMed ID: 26564230
[TBL] [Abstract][Full Text] [Related]
7. Acute kidney injury during cisplatin therapy and associations with kidney outcomes 2 to 6 months post-cisplatin in children: a multi-centre, prospective observational study.
McMahon KR; Lebel A; Rassekh SR; Schultz KR; Blydt-Hansen TD; Cuvelier GDE; Mammen C; Pinsk M; Carleton BC; Tsuyuki RT; Ross CJD; Huynh L; Yordanova M; Crépeau-Hubert F; Wang S; Palijan A; Lee J; Boyko D; Zappitelli M;
Pediatr Nephrol; 2023 May; 38(5):1667-1685. PubMed ID: 36260162
[TBL] [Abstract][Full Text] [Related]
8. Recent Advances in Models, Mechanisms, Biomarkers, and Interventions in Cisplatin-Induced Acute Kidney Injury.
Holditch SJ; Brown CN; Lombardi AM; Nguyen KN; Edelstein CL
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31226747
[TBL] [Abstract][Full Text] [Related]
9. Lung cancer-kidney cross talk induces kidney injury, interstitial fibrosis, and enhances cisplatin-induced nephrotoxicity.
Orwick A; Sears SM; Sharp CN; Doll MA; Shah PP; Beverly LJ; Siskind LJ
Am J Physiol Renal Physiol; 2023 Mar; 324(3):F287-F300. PubMed ID: 36727944
[TBL] [Abstract][Full Text] [Related]
10. The Predictive Role of the Biomarker Kidney Molecule-1 (KIM-1) in Acute Kidney Injury (AKI) Cisplatin-Induced Nephrotoxicity.
Tanase DM; Gosav EM; Radu S; Costea CF; Ciocoiu M; Carauleanu A; Lacatusu CM; Maranduca MA; Floria M; Rezus C
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31652595
[TBL] [Abstract][Full Text] [Related]
11. Flavonoid derivative DMXAA attenuates cisplatin-induced acute kidney injury independent of STING signaling.
Lu L; Liu W; Li S; Bai M; Zhou Y; Jiang Z; Jia Z; Huang S; Zhang A; Gong W
Clin Sci (Lond); 2023 Mar; 137(6):435-452. PubMed ID: 36815438
[TBL] [Abstract][Full Text] [Related]
12. Magnesium protects against cisplatin-induced acute kidney injury by regulating platinum accumulation.
Solanki MH; Chatterjee PK; Gupta M; Xue X; Plagov A; Metz MH; Mintz R; Singhal PC; Metz CN
Am J Physiol Renal Physiol; 2014 Aug; 307(4):F369-84. PubMed ID: 24944268
[TBL] [Abstract][Full Text] [Related]
13. N-acetylcysteine ameliorates cisplatin-induced renal senescence and renal interstitial fibrosis through sirtuin1 activation and p53 deacetylation.
Li C; Xie N; Li Y; Liu C; Hou FF; Wang J
Free Radic Biol Med; 2019 Jan; 130():512-527. PubMed ID: 30447351
[TBL] [Abstract][Full Text] [Related]
14. Galangin ameliorates cisplatin-induced nephrotoxicity by attenuating oxidative stress, inflammation and cell death in mice through inhibition of ERK and NF-kappaB signaling.
Huang YC; Tsai MS; Hsieh PC; Shih JH; Wang TS; Wang YC; Lin TH; Wang SH
Toxicol Appl Pharmacol; 2017 Aug; 329():128-139. PubMed ID: 28558962
[TBL] [Abstract][Full Text] [Related]
15. FGF21 is induced in cisplatin nephrotoxicity to protect against kidney tubular cell injury.
Li F; Liu Z; Tang C; Cai J; Dong Z
FASEB J; 2018 Jun; 32(6):3423-3433. PubMed ID: 29401620
[TBL] [Abstract][Full Text] [Related]
16. Nephroprotective Effects of Saponins from Leaves of Panax quinquefolius against Cisplatin-Induced Acute Kidney Injury.
Ma ZN; Li YZ; Li W; Yan XT; Yang G; Zhang J; Zhao LC; Yang LM
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28703736
[TBL] [Abstract][Full Text] [Related]
17. Signaling Rho-kinase mediates inflammation and apoptosis in T cells and renal tubules in cisplatin nephrotoxicity.
Nozaki Y; Kinoshita K; Hino S; Yano T; Niki K; Hirooka Y; Kishimoto K; Funauchi M; Matsumura I
Am J Physiol Renal Physiol; 2015 Apr; 308(8):F899-909. PubMed ID: 25651561
[TBL] [Abstract][Full Text] [Related]
18. Understanding the Risk Factors and Long-Term Consequences of Cisplatin-Associated Acute Kidney Injury: An Observational Cohort Study.
Bhat ZY; Cadnapaphornchai P; Ginsburg K; Sivagnanam M; Chopra S; Treadway CK; Lin HS; Yoo G; Sukari A; Doshi MD
PLoS One; 2015; 10(11):e0142225. PubMed ID: 26556481
[TBL] [Abstract][Full Text] [Related]
19. Cisplatin nephrotoxicity as a model of chronic kidney disease.
Shi M; McMillan KL; Wu J; Gillings N; Flores B; Moe OW; Hu MC
Lab Invest; 2018 Aug; 98(8):1105-1121. PubMed ID: 29858580
[TBL] [Abstract][Full Text] [Related]
20. Rutaecarpine derivative Cpd-6c alleviates acute kidney injury by targeting PDE4B, a key enzyme mediating inflammation in cisplatin nephropathy.
Liu XQ; Jin J; Li Z; Jiang L; Dong YH; Cai YT; Wu MF; Wang JN; Ma TT; Wen JG; Liu MM; Li J; Wu YG; Meng XM
Biochem Pharmacol; 2020 Oct; 180():114132. PubMed ID: 32622666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
